Nucala (Mepolizumab): First IL-5 Antagonist Monoclonal Antibody FDA Approved for Maintenance Treatment of Patients with Severe Asthma.
Loretta
L
Fala
Eur Respir J. 2003 Sep;22(3):470-7
14516137
Lancet. 2012 Aug 18;380(9842):651-9
22901886
N Engl J Med. 2014 Sep 25;371(13):1198-207
25199059
N Engl J Med. 2014 Sep 25;371(13):1189-97
25199060